Prudential Financial
IMNM icon

Prudential Financial’s Immunome IMNM Stock Holding History

Prudential Financial’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Buy
17,250
+1,490
+9% +$31.9K ﹤0.01% 2027
2026
Q1 		$345K Buy
+15,760
New +$351K ﹤0.01% 1983

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Prudential Financial's IMNM Position: Q2 2026 in Review

Prudential Financial increased its Immunome (IMNM) stake by 9.5% in Q2 2026, buying an estimated $31.9K and bringing the position to 17,250 shares worth $366K. The position accounts for ﹤0.01% of the portfolio, ranked #2027.

Prudential Financial first reported a position in IMNM in Q1 2026 and has held it in 2 quarters since. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Prudential Financial held 17,250 shares of Immunome worth $366K as of Q2 2026.
  • Prudential Financial bought 1,490 Immunome shares in Q2 2026, an estimated $31.9K.
  • Immunome made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2027 holding.
  • Prudential Financial first reported a position in Immunome in Q1 2026 and has held it in 2 quarters since.
  • 203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.